Intravenous Ascorbic Acid Protocol for Cancer Patients: Scientific Rationale, Pharmacology, and Clinical Experience

Functional Foods in Health and Disease
doi 10.31989/ffhd.v3i8.43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Functional Food Center

Related search

Intravenous Ascorbic Acid as an Adjuvant Therapy for Recombinant Erythropoietin in Hemodialysis Patients With Hyperferritinemia

Kidney International
Nephrology
1999English

Evaluation of Glutathione, Albumin and Ascorbic Acid Levels in Breast Cancer Patients

International Journal of Clinical Medicine
2013English

High-Dose Intravenous Ascorbic Acid: Ready for Prime Time in Traumatic Brain Injury?

Neurocritical Care
Critical CareNeurologyIntensive Care Medicine
2019English

Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2013English

Clinical Pharmacology of Pediatric Patients: Pharmacology of Antibiotics in Pediatrics

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2004English

Cannabinoid Pharmacology in Cancer Research: A New Hope for Cancer Patients?

European Journal of Pharmacology
Pharmacology
2016English

EXPRESS: United States Pulmonary Hypertension Scientific Registry (USPHSR): Rationale, Design, and Clinical Implications

Pulmonary Circulation
PulmonaryRespiratory Medicine
2019English

Intravenous Tranexamic Acid for Hyperacute Primary Intracerebral Hemorrhage: Protocol for a Randomized, Placebo-Controlled Trial

International Journal of Stroke
Neurology
2016English

Ascorbic Acid and Phosphatase Activity

Nutrition Reviews
MedicineNutritionDietetics
1943English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy